Introduction to Minorities Generally Underrepresented In Clinical Trials
Exploring Minorities Generally Underrepresented In Clinical Trials reveals several interesting facts. A doctor said lack of trust and opportunity are some of the factors that contribute to these low participation numbers.
Minorities Generally Underrepresented In Clinical Trials Comprehensive Overview
In this series, we answer: - How does diversity in Dr. Patricia Robinson, an oncologist, explains why The
Part 5 of the Speaker Event titled 'Pharma and the Growing Need for Patient Genetic Diversity' at the Festival of Genomics 2019.
Summary & Highlights for Minorities Generally Underrepresented In Clinical Trials
- Twenty three years after the NIH created the Revitalization Act to increase the number of women and
- Mayo Clinic consultant, Division of Cardiovascular Disease's Scott Wright, M.D., Sharonne Hayes, M.D., director, Office of Diversity ...
- This video is about Ways to Engage
- Editor's note: A graphic in this segment misstated the abbreviations of one of the
- Clinical trials
Stay tuned for more updates related to Minorities Generally Underrepresented In Clinical Trials.